Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sylatron for Pediatric Craniopharyngioma
NCT01964300Phase 2Terminated
- Sponsor
- Pediatric Brain Tumor Consortium
- Start
- Apr 2014
- Primary completion
- Dec 2018
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in craniopharyngioma, sponsored by Pediatric Brain Tumor Consortium. Started Apr 2014; status: terminated.
02
Drugs
peginterferon alfa-2b
03
Conditions
craniopharyngioma
Beyond the preview
Go deeper on NCT01964300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964300.